Search results

• 2018

  Improvement in Hepatic Encephalopathy with Rifaximin Is Associated with Distinct Changes in the Metagenomic Species in the Saliva and Stool Microbiome and a Reduction in Systemic Inflammation - Results of the Rifsys Randomized Controlled Trial.

  Patel, V. C., McPhail, M. J., Zamalloa, A., Stoy, S., Vijay, G. K. M., Witherden, E., Lee, S., Shoaie, S., Huang, X., Rogers, G., Choo, J., Zia, R., Edwards, L., Gray, E., Woodhouse, C. A., Gencer, S., Cohen, M., Wendon, J., Erhlich, S. D. & Bruce, K. & 1 others, Shawcross, D. L., Dec 2018, In: Hepatology. 68, 6, p. 1462A-1463A

  Research output: Contribution to journal › Meeting Abstract › peer-review